This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barsyte-Lovejoy, D. Articles by Penn, L. Z. Search for Related Content PubMed PubMed Citation Articles by Barsyte-Lovejoy, D. Articles by Penn, L. Z.

The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis

Divisions of ¹ Cancer Genomics and Proteomics, ² Signaling Biology, and ³ Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital; Departments of ⁴ Medical Biophysics and ⁵ Laboratory Medicine and Pathobiology, ⁶ Computer Science, University of Toronto, Canada; and ⁷ Fred Litwin Cancer Genetics Center, Samuel Lunenfeld Research Institute Mount Sinai Hospital, Toronto, Ontario, Canada

Requests for reprints: Linda Z. Penn, Division of Cancer Genomics and Proteomics, Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, Toronto, Canada M5G 2M9. Phone: 416-946-2276; Fax: 416-946-2840; E-mail: lpenn{at}uhnres.utoronto.ca.

The product of the MYC oncogene is widely deregulated in cancer and functions as a regulator of gene transcription. Despite an extensive profile of regulated genes, the transcriptional targets of c-Myc essential for transformation remain unclear. In this study, we show that c-Myc significantly induces the expression of the H19 noncoding RNA in diverse cell types, including breast epithelial, glioblastoma, and fibroblast cells. c-Myc binds to evolutionarily conserved E-boxes near the imprinting control region to facilitate histone acetylation and transcriptional initiation of the H19 promoter. In addition, c-Myc down-regulates the expression of insulin-like growth factor 2 (IGF2), the reciprocally imprinted gene at the H19/IGF2 locus. We show that c-Myc regulates these two genes independently and does not affect H19 imprinting. Indeed, allele-specific chromatin immunoprecipitation and expression analyses indicate that c-Myc binds and drives the expression of only the maternal H19 allele. The role of H19 in transformation is addressed using a knockdown approach and shows that down-regulation of H19 significantly decreases breast and lung cancer cell clonogenicity and anchorage-independent growth. In addition, c-Myc and H19 expression shows strong association in primary breast and lung carcinomas. This work indicates that c-Myc induction of the H19 gene product holds an important role in transformation. (Cancer Res 2006; 66(10): 5330-7)

This article has been cited by other articles:

				A. Gabory, M.-A. Ripoche, A. Le Digarcher, F. Watrin, A. Ziyyat, T. Forne, H. Jammes, J. F. X. Ainscough, M. A. Surani, L. Journot, et al. H19 acts as a trans regulator of the imprinted gene network controlling growth in mice Development, October 15, 2009; 136(20): 3413 - 3421. [Abstract] [Full Text] [PDF]

				P. C. Boutros, S. K. Lau, M. Pintilie, N. Liu, F. A. Shepherd, S. D. Der, M.-S. Tsao, L. Z. Penn, and I. Jurisica Prognostic gene signatures for non-small-cell lung cancer PNAS, February 24, 2009; 106(8): 2824 - 2828. [Abstract] [Full Text] [PDF]

				S. Aviel-Ronen, B. P. Coe, S. K. Lau, G. da Cunha Santos, C.-Q. Zhu, D. Strumpf, I. Jurisica, W. L. Lam, and M.-S. Tsao Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features PNAS, July 22, 2008; 105(29): 10155 - 10160. [Abstract] [Full Text] [PDF]

				S. K. Lau, P. C. Boutros, M. Pintilie, F. H. Blackhall, C.-Q. Zhu, D. Strumpf, M. R. Johnston, G. Darling, S. Keshavjee, T. K. Waddell, et al. Three-Gene Prognostic Classifier for Early-Stage Non Small-Cell Lung Cancer J. Clin. Oncol., December 10, 2007; 25(35): 5562 - 5569. [Abstract] [Full Text] [PDF]

				S. S. Kim, M. Shago, L. Kaustov, P. C. Boutros, J. W. Clendening, Y. Sheng, G. A. Trentin, D. Barsyte-Lovejoy, D. Y.L. Mao, R. Kay, et al. CUL7 Is a Novel Antiapoptotic Oncogene Cancer Res., October 15, 2007; 67(20): 9616 - 9622. [Abstract] [Full Text] [PDF]

				C.-Q. Zhu, S. N. Popova, E. R. S. Brown, D. Barsyte-Lovejoy, R. Navab, W. Shih, M. Li, M. Lu, I. Jurisica, L. Z. Penn, et al. Integrin {alpha}11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells PNAS, July 10, 2007; 104(28): 11754 - 11759. [Abstract] [Full Text] [PDF]

				J. S. Mattick A new paradigm for developmental biology J. Exp. Biol., May 1, 2007; 210(9): 1526 - 1547. [Abstract] [Full Text] [PDF]

				K. V. Prasanth and D. L. Spector Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum Genes & Dev., January 1, 2007; 21(1): 11 - 42. [Abstract] [Full Text] [PDF]